Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 40 and 90 years old
- People who have had a specific type of stroke (called a lacunar ischemic stroke), confirmed by a brain MRI scan done within the past year
- People whose stroke-related disability is rated at a moderate level or below (a score of 3 or less on a standard disability scale), meaning they are either fully independent or need some help with walking
Who may not be able to join:
- People who have taken vitamin supplements or polyphenol supplements in the 30 days before joining
- People who have an overactive thyroid gland (hyperthyroidism)
- People with a disability rating above 3 on the standard scale, a serious illness, or an expected life expectancy of less than 12 months
- People who have difficulty swallowing that would prevent them from taking the study capsules
- People who have allergies or intolerance to halophytes (a type of salt-tolerant plant — confirm with trial site if unsure what this includes)
- People who are pregnant or breastfeeding
- People with an active cancer diagnosis
- People who are currently taking part in another clinical study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34608114878
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Six-minute walk test (6MWT); Neuropsychological questionnaires: Montreal Cognitive Assessment (MOCA); Blood laboratory parameters (homocysteine µmol/L).; Morisky-Green test count of returned treatment capsules.; Severity of the adverse event.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.